NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

MRNA versus NWBO (not a competition in any way) in terms of market cap:

MRNA's almost 8 billion market cap is a mirror how market is corrupted or working. Yes its pipelines are promising as of yet despite all in early phase I trials and it may embark on a phase 2 trial soon pending FDA approval. Remember too many biotech companies with early promising products in early trials have faded away unnoticed, and it's difficult or lucky to be able to move such products into phase 3 trial.

I have seen and experienced too many such companies (half long and half short in my investment), and now I almost don't invest in any company without a phase 3.

With the support of both big Pharms and the Wall Street money, MRNA can maintain a market cap of around 8 billion despite its very early in the game of the company.

On the other hand, NWBO, now in the cusp of Phase 3 data revelation and commercialization, has capped around 150 million ~ 200 million by the market (yes we are all familiar with this story and its implications of NWBO's platform so no more details to be repeated here).

The contrast is unbelievably startling and absurdly insulting!

The truth is when conception changes, everything will and has to change with justifiable market cap.

[Anybody still think we will only be trading with a market cap of 1 or 2 billion when we have successful trial data? SORRY, THERE WILL BE NO CHEAP SHARES.]